Triglyceride-Rich Lipoproteins and ASCVD: Evidence for Causality and Challenges in Therapeutic Translation.

Björnson E, Adiels M

Open source

DOI
10.1007/s11883-026-01442-y
Published
2026 Jul 20
Container
Current atherosclerosis reports
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s11883-026-01442-y,
  title = {Triglyceride-Rich Lipoproteins and ASCVD: Evidence for Causality and Challenges in Therapeutic Translation.},
  author = {Björnson E and Adiels M},
  year = {2026},
  journal = {Current atherosclerosis reports},
  doi = {10.1007/s11883-026-01442-y},
  url = {https://doi.org/10.1007/s11883-026-01442-y}
}

RIS

TY  - JOUR
TI  - Triglyceride-Rich Lipoproteins and ASCVD: Evidence for Causality and Challenges in Therapeutic Translation.
AU  - Björnson E
AU  - Adiels M
PY  - 2026
JO  - Current atherosclerosis reports
DO  - 10.1007/s11883-026-01442-y
UR  - https://doi.org/10.1007/s11883-026-01442-y
ER  - 

APA

E, B., & M, A. (2026). Triglyceride-Rich Lipoproteins and ASCVD: Evidence for Causality and Challenges in Therapeutic Translation.. Current atherosclerosis reports. https://doi.org/10.1007/s11883-026-01442-y

Source records